PRTN3 and rheumatoid arthritis: Autoantibodies, mainly ACPA, are thought to play a key role in RA pathogenesis; nonetheless, it seems evident that the knowledge about the pathogenesis, treatment response and clinical course of seronegative RA, is still limited [10,11].